Está en la página 1de 13

DRUG STUDY

August 13, 2009

1. HERACLENE capsule OD incorporated to milkfeeding

ACTION NURSING CONSIDERATION


ASSESSMENT HEALTH
PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
>Increases the Absorption: -premature
protein -oral babies
efficiency administration -low birth
coefficient, i.e., weight
the percentage -retarded
of bound growth
nitrogen for -poor appetite
protein build in infants,
up in the body children and
compared to adults
ingested -adjuvant to
nitrogen with treatment of
food intake. tuberculosis
The initial sign and other
is manifested chronic
by ailments
-convalescence
ACTION NURSING CONSIDERATION
ASSESSMENT HEALTH
PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
a marked from acute
increased in infection or
appetite. surgery
-faulty
nutrition in
older people

September 9, 2009

2. NALBUPHINE 0.06mL q6o TIVT

NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
>Binds with Absorption: -relief of *Hypersensitivit *Misuse may -sedation 1. Assess 1. Discuss in
opiate -Well (SC/IM) moderate to y *Pregnancy cause -drowsiness patient’s detail all aspects
receptors in -Complete severe pain psychological -sweating underlying of the drug
the CNS (IV) -pre-op and physical -nausea condition therapy: reason
altering Distribution: analgesia dependence -dry mouth before for taking drug
perception -Crosses -supplement and tolerance -dizziness therapy. and expected
to results.
NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
and placenta balanced -headache 2. Monitor VS 2. Discuss with
emotional Metabolism: anesthesia -vomiting after patient that
response to -Liver -surgical parenteral dizziness,
pain. Excretion: anesthesia route. Monitor drowsiness, and
>Relieves -Feces, -obstetrical for respiratory confusion are
pain kidneys, anesthesia distress, common. Instruct
Unchanged assess patient to change
(small respiratory position slowly to
amounts) rate, character prevent
and rhythm. orthostatic
Report hypotension and
respiratory avoid getting up
rate <10/min. without
Watch out for assistance.
muscle 3. Advice patient
rigidity. to refrain from
3. Monitor for taking CNS
possible depressants
adverse (alcohol,
reactions. sedative/hypnotic
4. Monitor s)
allergic for at least 24 hrs
reactions. after taking this

NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
5. Assess drug.
patient’s and 4. Instruct patient
family’s to report signs
knowledge of and symptoms of
drug therapy. adverse drug
reaction.
5. Teach patient
to turn, cough,
and breathe
deeply after
surgery to prevent
atelectasis.

3. CALMOSEPTINE ointment over a cellophane at the peri-ileostomy area BID


NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
>zinc oxide Absorption: -protects, *Pregnancy *Avoid contact *no data 1. Assess for 1. Discuss in
particularly the soothes and and lactation w/ mouth or history of detail all
allergy aspects
NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
fine particles of helps promote *Deep skin eyes Allergic to zinc, of the drug
the oxide have healing in wounds and reaction: dimethicone, therapy:
deodorizing those with severe burns -hives lanolin, cod reason for
and impaired skin -difficulty liver oil, taking drug
antibacterial integrity breathing petroleum and expected
actions. related to -swelling of jelly, parabens, results.
feeding tube face, lips, mineral oil, or 2. Practice
site leakage, tongue, or wax. thorough
wound throat sanitary
drainage, fetal hygiene.
and urinary 2. Notify the
incontinence, physician if
bedsores, etc. signs of
infection such
as redness and
warmth or

4. ELICA CREAM at periumbilical area OD

NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
>Mometasone Absorption: -Relief of *Hypersensitivit *Pregnancy Rare: 1. Document 1. Instruct
furoate, a -undetected in inflammatory y to *Pediatric -paresthesia onset, duration patient to use
synthetic plasma & pruritic mometasone patients -pruritus and character regularly as
corticosteroid, although manifestations furoate *Systemic -burning of symptoms. directed.
exhibits anti- some may be of absorption - 2. Attempt to 2. Advise
inflammatory, swallowed corticosteroid- may be tingling/stinging identify patient to
antipruritic and Distribution: responsive increased if -signs of skin triggers. identify
vasoconstrictiv -98-99% dermatoses. extensive atrophy 3. Monitor for triggers and
e properties. bound to -May be body surface systemic practice
plasma applied to are treated. absorption:feve avoidance.
protein scalp lesions. Long-term use r. 3. Instruct to
Metabolism: in infant & 4. Monitor for report failure
-liver childn. *Avoid possible drug to improve
Excretion: contact w/ induced condition after
-liver and eyes. adverse 3-5 days of
kidney *Pregnancy reactions. therapy.
and lactation. 5. Assess for 4. Teach
patient’s and patient to limit
family’s
knowledge on
drug therapy.
NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
treatment for
14 days.
5. Instruct
patient to
monitor for
and report
drug induced
adverse
reactions.

September 12, 2009

5. CEFTRIAXONE 250 mg IV OD for 30 mins.

NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
>Inhibits Absorption: -treatment for *Hypersensitivit *Pregnancy -pain, 1. Assess 1. Instruct patient
bacterial -IM, IV susceptible y to and lactation induration, patient’s to take medication
cell wall administratio cephalosporins, *with history of phlebitis after previous as prescribed for
n
NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
synthesis, Distribution: infections penicillins, gastrointestina IV sensitivity the length of time
rendering -wide, good such as lidocaine or any l disease administration reaction to ordered even if he
cell wall CSF chancroid, other local *Nephrotoxicit , rash, penicillin or feels better.
osmotically penetration gastroenteritis anesthetic y concomitant diarrhea, other 2. Teach patient to
unstable, Metabolism: , Lyme product of the administration eosinophilia cephalosphorin report sore throat,
leading to -Liver, disease, etc. amide type w/ -elevation of s. bruising, bleeding
cell death partially -treatment of *Neonates and aminoglycosid AST, ALT, BUN 2. Assess and joint pain
metabolized LRTI, skin and premature es and patient for indicative of blood
Excretion: soft tissue infants with *Rare: PT creatinine. signs and dyscrasia (rare).
-Kidneys infections, bilirubin alterations esp. -GI symptoms of 3. Advise patient
primarily, complicated encephalopathy to patients disturbances infection before to watch out for
liver and *Peristalsis- with impaired -hematologic and during perineal itching,
minimally uncomplicated inhibiting Vit. K synthesis changes treatment. fever, malaise,
UTI preparations or low Vit. K -skin reactions 3. Obtain C&S redness, pain,
-pre-operative *Prophyria, stores -vaginitis due before swelling, drainage,
prophylaxis to unapplianced *Anaphylactic to C. albicans beginning drug etc. indicative of
reduce chance auricular- shock esp. to proliferation therapy to superinfection.
of post- ventricular premature identify if 4. Advise patient
operative block; neonates correct to report bloody,

surgical cardiogenic *Severe renal treatment has


infections or hepatic been initiated.
insufficiency
NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
shock IV 4. Assess for mucoid diarrhea
administration allergic and which may indicate
, rash, anaphylactic pseudomembrano
diarrhea, reactions. us colitis.
eosinophilia 5. Assess renal
-elevation of function before
AST, ALT, BUN and during
and therapy.
creatinine. 6. Monitor
-GI hematologic,
disturbances electrolyte and
-hematologic hepatic status
changes if patient is on
-skin reactions long term
-vaginitis due therapy.
to C. albicans 7. Assess for
proliferation possible
superinfection.

September 13, 2009

6. OMEPRON 20 mg IV OD

NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
>Suppresses Absorption: -short-term *Hypersensitivit *Pregnancy, -angina 1. Assess other 1. Take before
gastric -rapidly treatment of y lactation and -tachycardia medications meals.
secretion by absorbed active *Lactation and children -bradycardia patient may be 2. Do not crush
inhibiting Distribution: duodenal children *Possible -palpitation taking for or chew
hydrogen/ -protein ulcer, benign *Combination gastric ulcer -headache effectiveness capsules.
potassium binding (95%) gastric ulcer, therapy with *Hepatic -dizziness and 3. Delayed
ATPase -gastric GERD clarithromycin impairment -rash interactions. release
enzyme parietal cells -long-term for patient w/ -diarrhea 2. Monitor capsule may
system in the Metabolism: treatment of hepatic -abdominal therapeutic be opened and
gastric parietal -Liver pathologic impairment pain effectiveness contents
cell: extensively hypersecretory -acid and added to apple
characterized -by CYP450 conditions regurgitation interactions. sauce.
as a gastric enzyme sytem (e.g. Zollinger- -nausea 3. Assess GI 4. Caution
acid pump Excretion: Ellison -vomiting system: bowel patient to
avoid alcohol,
inhibitor, since -Kidneys syndrome, -cough sounds 8 hrly,
salicylates,
it blocks the -feces multiple -back pain abdomen for ibuprofen: may
final step of endocrine pain and cause GI

acid adenomas) swelling, loss of


production appetite.
NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
Half-life: 4. Monitor irritation.
-30 mins-1 hr hepatic 5. Small
-increase in enzymes. frequent meals
elderly 5. Assess may help to
-hepatic knowledge/teac maintain
diseases h appropriate nutrition.
use of 6. Report
medication, severe
interventions to headache,
reduce side unresolved
effects and diarrhea or
report adverse changes in
symptoms. respiratory
status.
7. Inform
physician if
patient is or
intends to
become
pregnant.
Breastfeeding
is
NURSING CONSIDERATION
ASSESSMENT HEALTH
ACTION PHARMACO- INDICATION CONTRA- PRECAUTION ADVERSE
EDUCATION
KINETICS INDICATION REACTION
not
recommended.
*The patient was prescribed with 30 medications from July 20 until September 13, 2009. However, only the six (6) drugs indicated above
were discussed and given prior significance for this case study.